3.31
Bioharvest Sciences Inc (BHST) 最新ニュース
BHST PE Ratio & Valuation, Is BHST Overvalued - Intellectia AI
BioHarvest Sciences Q1 2025 Earnings: EPS Misses Estimates While Stock Sees Positive ReactionSegment Revenue Breakdown - newsline.com
BioHarvest Sciences Inc. (BHST) Advances 2.75% as Shares Hold Above Key SupportLong Setup Ideas - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: Higher Losses Weigh on Operational ProgressEarnings Preview - newsline.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
BioHarvest Sciences (BHST) Gains Nearly 1% as Shares Test Key ResistanceUp Down Ratio - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesPerformance Review - newsline.com
BHST Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Revision Upgrade - newsline.com
BioHarvest (BHST) Q4 2025 Earnings Transcript - AOL.com
BioHarvest Sciences (BHST) Retreats to Key Support Level After Modest DeclinePrice Action Signals - newsline.com
BioHarvest Sciences Files Form 6-K With Meeting Materials for Upcoming Shareholder Vote - TipRanks
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor - Stock Titan
BioHarvest Sciences Inc. (BHST) Edges Higher as Price Approaches Resistance After Support TestHigh Dividend Factor - The Legal Advocate
Tate & Lyle expands BioHarvest partnership for next-gen sweetener innovation - FoodTechBiz
BioHarvest Sciences Inc. (BHST) Edges Higher as Trading Volume Picks UpPercent Above MA - The Legal Advocate
BioHarvest Sciences Inc. (BHST) Finds Support, Bounces to $3.86Double EMA - The Legal Advocate
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation - TMX Newsfile
BioHarvest Sciences (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Navigates Early-Stage CommercializationRevenue Inflection Point - The Legal Advocate
Bioharvest Sciences Signals Progress Amid Near-Term Losses - TipRanks
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Yahoo! Finance Canada
Tate & Lyle expands collaboration with BioHarvest to accelerate next-generation sweetener innovation - Asia Food Journal
BioHarvest (BHST) Q1 2026 Earnings Transcript - AOL.com
BioHarvest expands Tate & Lyle sweetener development deal By Investing.com - Investing.com Australia
Tate & Lyle expands plant-based sweetener innovation partnership with BioHarvest Sciences - New Food
BioHarvest expands Tate & Lyle sweetener development deal - Investing.com UK
BioHarvest Sciences Q1 earnings call highlights - MSN
BioHarvest outlines 2026 revenue of $38M-$42M in D2C and $12M-$14M in CDMO activity while targeting 2H 2027 fragrance production - MSN
H.C. Wainwright Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $14 - Moomoo
BioHarvest Sciences Inc. Common Stock Q1 2026 Earnings Call Summary - Yahoo Finance
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: - GuruFocus
BioHarvest Sciences (NASDAQ:BHST) Announces Quarterly Earnings Results - MarketBeat
BioHarvest Sciences Inc. (BHST) reports Q4 loss, lags revenue estimates - MSN
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
BioHarvest Sciences Posts Q1 2026 Growth and Advances Botanical Synthesis Deals - TipRanks
BioHarvest Sciences: Q1 revenue up 8% YoY, CDMO revenue up 135%, net loss at $2.6M, gross margin at 59% - TradingView
BioHarvest Sciences (NASDAQ: BHST) posts Q1 2026 growth with $8.5M revenue - Stock Titan
Small cap wrap: VivoPower, BioHarvest Sciences, Phunware, Tiziana Life Sciences… - Proactive financial news
BioHarvest Sciences Files Q1 2026 Financials on Form 6-K - TipRanks
BioHarvest Sciences Q1 2026 Earnings Call Transcript - MarketBeat
BioHarvest Sciences (NASDAQ: BHST) grows Q1 2026 revenue while warning on going concern - Stock Titan
BioHarvest Sciences Names New Business Development Chief to Drive CDMO Growth - TipRanks
大文字化:
|
ボリューム (24 時間):